Assessment
AI-powered eligibility analysis and therapeutic strategy. Determining which modalities are viable for the patient's specific mutation.
Active Programs
Programs we're moving forward.
Nome is currently managing therapeutic development programs across multiple disease areas and modalities — from assessment through regulatory submission.
Current Pipeline
10+ active programs. One shared method.
Neurology
Retinal
Other Conditions
Gene Therapy
—
—
ASOs
We also provide advisory services on a large portfolio of programs.
Development Stages
The path every program walks
A guided route from first call to regulatory filing. Predictable milestones, transparent handoffs.
Blueprint
Full development plan, competitive RFP, partner selection, and contracting. The roadmap from target validation through preclinical development.
Preclinical
Active experiments underway with contracted partners. Ongoing program management, scientific oversight, and milestone tracking.
Regulatory
IND submission, FDA coordination, and expanded access navigation.
